tradingkey.logo
搜索

Smith & Nephew PLC

SNN
添加自选
30.290USD
+0.250+0.83%
收盘 06/29, 16:00美东报价延迟15分钟
12.81B总市值
26.95市盈率 TTM

关于 Smith & Nephew PLC 公司

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Smith & Nephew PLC简介

公司代码SNN
公司名称Smith & Nephew PLC
上市日期Sep 18, 2087
CEONath (Deepak S)
员工数量17349
证券类型Depository Receipt
年结日Sep 18
公司地址Building 5
城市WATFORD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United Kingdom
邮编WD18 8YE
电话4401923477100
网址https://www.smith-nephew.com/
公司代码SNN
上市日期Sep 18, 2087
CEONath (Deepak S)

Smith & Nephew PLC公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.29K
+1.70%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.19K
+4.86%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+2.57%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%

常见问题

Smith & Nephew PLC的前五大股东是谁?

Smith & Nephew PLC 的前五大股东如下:Dr. Ajay Dhankhar, Ph.D.

有多少机构持有Smith & Nephew PLC(SNN)的股份?

截至2026Q1,共有471家机构持有Smith & Nephew PLC的股份,合计持有的股份价值约为30.95M,占公司总股份的7.25%。与2025Q4相比,机构持股有所增加,增幅为-11491314.00。

哪个业务部门对Smith & Nephew PLC的收入贡献最大?

在2026Q1,Sports Medicine Joint Repair业务部门对Smith & Nephew PLC的收入贡献最大,创收1.07B,占总收入的17.31%。
KeyAI